Styliani Stella Daskalopoulou, MD, MSc, DIC, PhD
Primary Axis:
Cardiovascular Diseases and Critical Care
Email:
Email contact form Research Focus:
The theme of the research program is the identification of early markers of vascular impairment and maintenance of vascular health. The intention is to integrate biomedical technology into an innovative cardiovascular research program aimed at unraveling the atherosclerotic process, and identifying early markers of severity, progression of vascular disease, and efficacy of treatment.
Keywords:
Cardiovaslucar diseases, Artherosclerosis, Biomedical technology, Digital image analysis, Metabolic syndrome, Hypertension, Dislipidemia, Smoking, Vascular disease prevention, Risk factor modifications
Location:
Montreal General Hospital Publications:
Daskalopoulou SS, Daskalopoulos ME, Theocharis S, Kavantzas N, Perrea D, Karandrea D, Constantinides AG, Mikhailidis DP, Nicolaides AN, Liapis CD. Metallothionein expression in the high-risk carotid atherosclerotic plaque. Curr Med Res Opin 2007;23(3):659-670.
Daskalopoulou SS, Pathmarajah M, Kakkos SK, Daskalopoulos ME, Holloway PA, Mayo NE, Mikhailidis DP, Geroulakos G. Association between ankle-brachial index and risk factor profile in newly diagnosed patients with peripheral arterial disease. Circ J 2008;72(3):441-448.
Daskalopoulou SS, Delaney JA, Filion KB, Brophy JM, Mayo NE, Suissa S. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J 2008;29(17):2083-2091.
